Clinical Trial Update: A Study to Assess the Efficacy and Safety of ABTL0812 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating ABTL0812 for endometrial cancer and squamous non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• ABTL0812

Snippet

Sponsor: Ability Pharmaceuticals SL | Conditions: Endometrial Cancer, Squamous Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED